PALB2 Gene Function
Partner And Localizer Of BRCA2
Overview
PALB2 connects BRCA1 with BRCA2 and helps position the BRCA2–RAD51 machinery at DNA double-strand breaks. Pathogenic germline variants can increase breast and pancreatic cancer risk and may contribute to homologous-recombination deficiency after biallelic loss.
Molecular Mechanism
Detailed mechanism data is not yet available for PALB2.
Key Pathways
- ·Homologous recombination
- ·DNA double-strand break repair
- ·Fanconi anaemia pathway
Disease Associations
- ·Hereditary breast cancer
- ·Pancreatic cancer predisposition
- ·Fanconi anaemia
Research Activity
PALB2 is an actively studied target: about 40+ clinical trials that mention it are currently recruiting on ClinicalTrials.gov. Trial activity reflects research interest, not proven benefit — designs, endpoints and populations vary widely.
Track PALB2 trials
New and changed oncology trials, summarised in plain language each day.
Functional Partners
Common Questions About PALB2
What does PALB2 do?
PALB2 participates in Homologous recombination, DNA double-strand break repair, Fanconi anaemia pathway. PALB2 connects BRCA1 with BRCA2 and helps position the BRCA2–RAD51 machinery at DNA double-strand breaks. Pathogenic germline variants can increase breast and pancreatic cancer risk and may contribute to homologous-recombination deficiency after biallelic loss.
Why is PALB2 relevant to cancer research?
Its reported relevance includes Hereditary breast cancer, Pancreatic cancer predisposition, Fanconi anaemia. The exact alteration, assay and disease context determine what a result can support.